Eckert & Ziegler SE

Eckert & Ziegler raises its forecast for the current financial year once again

Eckert & Ziegler and Telix Pharmaceuticals Enter into a Collaboration and Licence Agreement for Actinium-225

Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year

Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024.

Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.

Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.